Gordon Crosby

1.1k total citations · 1 hit paper
15 papers, 931 citations indexed

About

Gordon Crosby is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Gordon Crosby has authored 15 papers receiving a total of 931 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 14 papers in Cellular and Molecular Neuroscience and 1 paper in Organic Chemistry. Recurrent topics in Gordon Crosby's work include Receptor Mechanisms and Signaling (15 papers), Neuroscience and Neuropharmacology Research (8 papers) and Neuropeptides and Animal Physiology (7 papers). Gordon Crosby is often cited by papers focused on Receptor Mechanisms and Signaling (15 papers), Neuroscience and Neuropharmacology Research (8 papers) and Neuropeptides and Animal Physiology (7 papers). Gordon Crosby collaborates with scholars based in United States. Gordon Crosby's co-authors include William Billard, Vilma Ruperto, Louis C. Iorio, Allen Barnett, Herbert Binch, Richard McQuade, Ruth A. Duffy, Jean E. Lachowicz, Richard E. Chipkin and John W. Clader and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Neurochemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Gordon Crosby

15 papers receiving 855 citations

Hit Papers

Characterization of the binding of 3H-SCH 23390, a select... 1984 2026 1998 2012 1984 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gordon Crosby United States 11 615 574 156 83 71 15 931
William Billard United States 13 710 1.2× 640 1.1× 175 1.1× 88 1.1× 86 1.2× 24 1.1k
Jacques Vignon France 20 912 1.5× 849 1.5× 106 0.7× 86 1.0× 66 0.9× 54 1.4k
J.M. Kamenka France 16 692 1.1× 607 1.1× 88 0.6× 88 1.1× 49 0.7× 38 1.0k
Sylvie Perachon France 8 716 1.2× 578 1.0× 115 0.7× 68 0.8× 101 1.4× 10 985
C. Malgouris France 15 660 1.1× 455 0.8× 85 0.5× 66 0.8× 96 1.4× 25 947
Raymond P. Ward United States 7 715 1.2× 491 0.9× 115 0.7× 100 1.2× 114 1.6× 7 954
Tracey Gager United Kingdom 9 578 0.9× 464 0.8× 146 0.9× 103 1.2× 74 1.0× 10 783
Porntip Supavilai Thailand 24 1.0k 1.7× 844 1.5× 105 0.7× 106 1.3× 123 1.7× 43 1.5k
Hyacinth C. Akunne United States 24 1.0k 1.7× 925 1.6× 248 1.6× 84 1.0× 49 0.7× 49 1.5k
Shin‐ichi Yatsugi Japan 20 528 0.9× 378 0.7× 53 0.3× 108 1.3× 99 1.4× 38 897

Countries citing papers authored by Gordon Crosby

Since Specialization
Citations

This map shows the geographic impact of Gordon Crosby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gordon Crosby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gordon Crosby more than expected).

Fields of papers citing papers by Gordon Crosby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gordon Crosby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gordon Crosby. The network helps show where Gordon Crosby may publish in the future.

Co-authorship network of co-authors of Gordon Crosby

This figure shows the co-authorship network connecting the top 25 collaborators of Gordon Crosby. A scholar is included among the top collaborators of Gordon Crosby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gordon Crosby. Gordon Crosby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Clader, John W., William Billard, Herbert Binch, et al.. (2003). Muscarinic M2 antagonists: anthranilamide derivatives with exceptional selectivity and in vivo activity. Bioorganic & Medicinal Chemistry. 12(2). 319–326. 18 indexed citations
2.
Vice, Susan F., Samuel Chackalamannil, Stuart W. McCombie, et al.. (2002). Enhancement of pharmacokinetic properties and in vivo efficacy of benzylidene ketal M2 muscarinic receptor antagonists via benzamide modification. Bioorganic & Medicinal Chemistry Letters. 12(23). 3479–3482. 5 indexed citations
3.
Kozlowski, Joseph A., Guowei Zhou, Jayaram R. Tagat, et al.. (2002). Substituted 2-(R)-Methyl piperazines as muscarinic M2 selective ligands. Bioorganic & Medicinal Chemistry Letters. 12(5). 791–794. 15 indexed citations
4.
Wang, Yuguang, Samuel Chackalamannil, Zhiyong Hu, et al.. (2002). Improving the Oral Efficacy of CNS Drug Candidates:  Discovery of Highly Orally Efficacious Piperidinyl Piperidine M2 Muscarinic Receptor Antagonists. Journal of Medicinal Chemistry. 45(25). 5415–5418. 9 indexed citations
5.
Carey, Galen, William Billard, Herbert Binch, et al.. (2001). SCH 57790, a selective muscarinic M2 receptor antagonist, releases acetylcholine and produces cognitive enhancement in laboratory animals. European Journal of Pharmacology. 431(2). 189–200. 59 indexed citations
6.
Lachowicz, Jean E., Ruth A. Duffy, Vilma Ruperto, et al.. (2001). Facilitation of acetylcholine release and improvement in cognition by a selective M2 muscarinic antagonist, SCH 72788. Life Sciences. 68(22-23). 2585–2592. 32 indexed citations
7.
Billard, William, Herbert Binch, Gordon Crosby, et al.. (2000). Diphenylsulfone muscarinic antagonists: piperidine derivatives with high m2 selectivity and improved potency. Bioorganic & Medicinal Chemistry Letters. 10(19). 2209–2212. 13 indexed citations
8.
Wang, Yuguang, Samuel Chackalamannil, Zhiyong Hu, et al.. (2000). Design and synthesis of piperidinyl piperidine analogues as potent and selective M2 muscarinic receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 10(20). 2247–2250. 85 indexed citations
9.
Kozlowski, Joseph A., Derek Lowe, Henry Guzik, et al.. (2000). Diphenyl sulfoxides as selective antagonists of the muscarinic M2 receptor. Bioorganic & Medicinal Chemistry Letters. 10(20). 2255–2257. 10 indexed citations
10.
Chackalamannil, Samuel, Sundeep Dugar, William Billard, et al.. (2000). Benzylidene ketal derivatives as M2 muscarinic receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 10(24). 2727–2730. 8 indexed citations
11.
Billard, William, Herbert Binch, Gordon Crosby, & Richard McQuade. (1995). Identification of the primary muscarinic autoreceptor subtype in rat striatum as m2 through a correlation of in vivo microdialysis and in vitro receptor binding data.. Journal of Pharmacology and Experimental Therapeutics. 273(1). 273–279. 93 indexed citations
12.
Tedford, Clark E., Gordon Crosby, Louis C. Iorio, & Richard E. Chipkin. (1992). Effect of SCH 39166, a novel dopamine D1 receptor antagonist, on [3H]acetylcholine release in rat striatal slices. European Journal of Pharmacology. 211(2). 169–176. 17 indexed citations
13.
McQuade, Robert D., Ruth A. Duffy, Gordon Crosby, et al.. (1991). [3H]SCH 39166, A New D1‐Selective Radioligand: In Vitro and In Vivo Binding Analyses. Journal of Neurochemistry. 57(6). 2001–2010. 32 indexed citations
14.
Billard, William, Gordon Crosby, Louis C. Iorio, Richard E. Chipkin, & A Barnett. (1988). Selective affinity of the benzodiazepines quazepam and 2-oxo-quazepam for BZ1 binding site and demonstration of 3H-2-oxo-quazepam as a BZ1 selective radioligand. Life Sciences. 42(2). 179–187. 18 indexed citations
15.
Billard, William, Vilma Ruperto, Gordon Crosby, Louis C. Iorio, & Allen Barnett. (1984). Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatum. Life Sciences. 35(18). 1885–1893. 517 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026